Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Commissioner Hamburg: White House Close To Formal Announcement

Executive Summary

Former New York City Health Commissioner Margaret Hamburg is preparing for her confirmation hearings as FDA commissioner, with the White House set to announce her nomination shortly
Advertisement

Related Content

FDA’s Goodman Is Rising Star Within Agency As Obama Team Coalesces
Are Two Heads Better Than One? Not At FDA
Are Two Heads Better Than One? Not At FDA
FDA’s Goodman Is Rising Star Within Agency As Obama Team Coalesces
FDA’s Goodman Moving Up: Named Acting Chief Medical Officer, Appointed To CER Panel
Two FDAs Rejected By Rep. Waxman, Says Fixing Food Safety Is First Priority
Hamburg, Sharfstein Nominations Shift Focus To Career FDAers’ Plans
Hamburg, Sharfstein Nominations Shift Focus To Career FDAers’ Plans
Duke’s Califf Bows Out Of FDA Search; Quest Moves To Baltimore, New York
Health Care Reform: Plan for Quick Action Dashed By Daschle Withdrawal

Topics

Advertisement
UsernamePublicRestriction

Register

PS050775

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel